Francesco Dazzi, MD, PhD, King's College Hospital NHS Foundation Trust, London, UK, discusses the current state of the art in mesenchymal stromal cell therapy and some challenges associated with their use. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).